Treatment of Atrial Fibrillation in Patients by Pulmonary Vein Isolation, Renal Artery Denervation or Both. (ASAF)
Prospective, randomized, controlled, multicenter, international clinical trial. The study population consist of patients with paroxysmal or persistent atrial fibrillation with out range hypertension or signs of sympathetic overdrive. Patient will be randomized into one of the following three groups.
group 1 : patients will undergo renal artery denervation/ group 2 : Patients will undergo pulmonary vein isolation/ group 3: Patients will undergo pulmonary vein isolation and renal artery denervation.
|Study start date||2014-04-10|